Abstract
Clostridium difficile bacteremia is rare. Here, we report two cases of C. difficile bacteremia in patients with significant underlying gastrointestinal pathology. In one case, the bacteremia was caused by the North American pulsed-field gel electrophoresis (PFGE) type 1 (NAP-1) strain, which is responsible for recent outbreaks of C. difficile infections of increased severity.
MeSH terms
-
Adult
-
Aged, 80 and over
-
Amikacin / therapeutic use
-
Anti-Bacterial Agents / therapeutic use*
-
Bacteremia / diagnosis
-
Bacteremia / drug therapy*
-
Bacteremia / epidemiology
-
Bacteremia / microbiology
-
Clostridioides difficile / classification*
-
Clostridioides difficile / drug effects
-
Clostridioides difficile / isolation & purification*
-
Clostridium Infections / diagnosis
-
Clostridium Infections / drug therapy*
-
Clostridium Infections / epidemiology
-
Clostridium Infections / microbiology
-
Comorbidity
-
Humans
-
Male
-
Ohio
-
Treatment Outcome
-
Vancomycin / therapeutic use
-
beta-Lactams / therapeutic use
Substances
-
Anti-Bacterial Agents
-
beta-Lactams
-
Vancomycin
-
Amikacin